tiprankstipranks
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Hong Kong Market
1011
China NT Pharma Group Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:1011 full AI Analyst Report?

China NT Pharma Group Co., Ltd. (1011) Income Statement

2 Followers

China NT Pharma Group Co., Ltd. Income Statement

Last quarter (Q4 2025), China NT Pharma Group Co., Ltd.'s total revenue was ¥12.16M, an increase of Infinity% from the same quarter last year. In Q4, China NT Pharma Group Co., Ltd.'s net income was ¥-9.13M. See China NT Pharma Group Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 24.16M¥ 37.96M¥ 7.37M¥ 207.09M¥ 226.70M
Gross Profit
¥ 9.61M¥ 5.26M¥ 7.37M¥ 125.29M¥ 145.46M
Operating Expenses
¥ 21.97M¥ 18.49M¥ 63.57M¥ 26.42M¥ 244.01M
Depreciation and Amortization
¥ 48.00K¥ 4.58M¥ 5.88M¥ 21.07M¥ 42.25M
EBITDA
¥ -12.32M¥ -8.65M¥ 1.33M¥ 10.39M¥ -17.78M
Operating Income
¥ -12.36M¥ -13.23M¥ -56.21M¥ -26.54M¥ -99.43M
Other Income/Expenses
¥ -13.89M¥ -40.25M¥ 22.84M¥ -23.50M¥ -49.32M
Pretax Income
¥ -26.25M¥ -53.48M¥ -33.37M¥ -50.04M¥ -148.75M
Net Income
¥ -26.04M¥ -53.36M¥ -143.59M¥ -66.41M¥ -149.54M
Per Share Metrics
Basic EPS
¥ -0.04¥ -0.20¥ -0.17¥ -0.04¥ -0.08
Diluted EPS
¥ -0.04¥ -0.20¥ -0.73¥ -0.04¥ -0.08
Weighted Average Shares Outstanding
 616.94M 264.09M 848.12M 1.90B 1.89B
Weighted Average Shares Outstanding (Diluted)
 616.94M 264.09M 197.82M 1.90B 1.89B
Currency in CNY

China NT Pharma Group Co., Ltd. Earnings and Revenue History